Anadi Algo News

dr m l jat people page on Anadi Algo News

People Landing|80 matching stories

dr m l jat News, Mentions & Market Context

AI-analyzed market coverage and mentions for dr m l jat, including related stories and trading context.

What Traders Do Next

A market theme is more useful with a process around it.

Use these pages to understand the story first. The clarity usually comes later, after the idea is filtered, tested, and put in context.

Translate It into Rules

See how a market theme can turn into a structured workflow instead of impulse.

Check the Setup

Use a validation step before any trade decision starts feeling obvious.

Read the Main Algo Guide

Start broad if you want to understand the workflow before you optimize the setup.

Here whenever you want to go deeper, never a nudge.Explore Anadi
Top Story|Economic Timesabout 18 hours ago

Why FIIs could continue moving out of largecaps and into mid and smallcaps: Motilal's Rajat Rajgarhia

If you look at India over a long period, the country has done well. However, the past two or three years have presented several challenges, including tariff-related and war-related issues.

Neutral
0

Impact Score

Mint1 day ago

HDFC Bank's next CEO: Kaizad Bharucha to replace Sashidhar Jagdishan? Report offers hint

Kaizad M Bharucha has been the Deputy Managing Director of the Bank since April 19, 2023. He is a career banker with over 35 years of experience.

Neutral
Economic Times3 days ago

GMR Group to explore opportunities for airports, adjacent biz in West Asia, Eastern Europe

GMR Group chairman G M Rao sees significant international airport opportunities. The company will explore growth in West Asia and Central Asia. Eastern Europe and Southeast Asia also present expansion possibilities. GMR Airports aims to scale up its asset-light portfolio globally. This strategy supports sustainable growth and financial discipline for the group.

Neutral
Mint5 days ago

Meta, Under Duress, Finally Does the Right Thing for Teens

Global regulatory scrutiny on tech giants, especially regarding user safety and data privacy, is intensifying. This can influence policy in other nations.

Bearish-3.370%
5 facts
Neutral for Indian markets, but watch for indirect regulatory risks for Indian tech/digital firms.|Quick check: MARUTI bearish bias (oversold), TATAMOTORS bearish bias (oversold).

Latest dr m l jat Mentions

Mint7 days ago+30.5

After the lottery win: why Dr Reddy’s may be doing much more in its laboratories

Neutral5 factsDRLPharma
Neutral to slightly cautious on DRL until clear signs of pipeline success emerge. Watch for R&D updates.|Quick check: DRL bullish bias (overbought), SUNPHARMA bearish bias (oversold).
Mint7 days ago+60.3

Multibagger defence stock Apollo Micro System acquires 34% stake in defence tech company

Neutral5 factsAPOLLODefenceAerospace & Defence
Maintain a bullish bias on defence stocks, particularly those with strong R&D and strategic government alignment, with a focus on long-term growth potential.|Quick check: APOLLO neutral (-1.0% 1d), NIFTY bullish bias (+7.9% 1d).
Economic Times11 days ago+5.8

BMW X1 LWB Launched in India: Check price, features, engine, interior space and what’s new in the long-wheelbase SUV

5 factsAutomobilesAuto Ancillaries
Maintain a neutral to slightly positive bias on auto ancillary stocks with exposure to premium segments, but exercise caution due to indirect impact.|Quick check: NIFTY neutral, BANKNIFTY neutral (+7.0% 1d).
Economic Times18 days ago+49.6

Gland Pharma appoints Dr Reddy’s senior executive Deepak Sapra as CEO

Bullish5 factsGLANDDRLPharma
Neutral to cautiously optimistic for Gland Pharma; await clarity on new CEO's strategic direction.|Quick check: GLAND bullish bias (overbought), DRL bullish bias (overbought).
Economic Times18 days ago+19.6

Narayana Health, NDB sign pact to share smart hospital expertise

Bearish5 factsNHHealthcareHospitals & Healthcare Services
Maintain a bullish bias on healthcare providers embracing digital transformation; look for entry points in NH with a focus on long-term growth potential.|Quick check: NH bearish bias (oversold), HDFCBANK bearish bias (oversold).
Economic Times19 days ago+22.5

India needs to step up public investment to attract private investments: Working paper by EAC-PM

5 factsBroad MarketAuto
Positive bias for capital goods, infrastructure, and manufacturing sectors; look for companies with strong order books.|Quick check: MARUTI bearish bias (-0.9% 1d), TATAMOTORS bearish bias (-1.4% 1d).
Economic Times20 days ago-53.9

Dr Agarwals Health shares fall 7% after Rs 2,065-crore block deal; Hyperion Investments, Claymore likely sellers

Neutral5 factsDRLALHealthcare
Maintain a cautious bias on DRLAL in the immediate term; consider short-term bearish trades or wait for price consolidation before initiating long positions.|Quick check: DRLAL neutral, TATASTEEL neutral (-1.3% 1d).
Economic Times27 days ago+8.9

Shift from production to agri-food value chains key to raise farm incomes: ICAR's Jat

4 factsEnergy
No immediate trade setup. Long-term positive for agri-processing and rural finance sectors.|Quick check: RELIANCE neutral (-0.8% 1d), ONGC neutral (-0.7% 1d).
Economic Times27 days ago+45.5

ICAR develops indigenous African Swine Fever vaccine, strengthening India’s biosecurity

Bullish5 factsAgricultureAnimal Health
Positive bias for companies in animal health and feed; look for long-term growth opportunities.|Quick check: MARUTI bullish bias (overbought), TATAMOTORS bullish bias (overbought).
Economic Times28 days ago+66.7

Dr Reddy's Laboratories launches generic Sugammadex injection in the United States

Bullish5 factsDRLPharmaceuticals
Maintain a bullish bias on Dr. Reddy's Laboratories (DRL) following this significant US generic launch, with potential for short-term upside. Risk management should include monitoring broader market sentiment and any regulatory changes in the US.|Quick check: DRL bullish bias (overbought), MARUTI neutral (-0.6% 1d).
Economic Times29 days ago+70.7

Nifty Q1 earnings grow 11% to beat estimate, says Motilal Oswal; picks Bharti Airtel, SBI, ICICI Bank among top bets

Bullish5 factsRELIANCEJSWSTEELICICIBANKBankingFinancial Services
Consider long positions in fundamentally strong banking stocks like ICICI Bank and SBI, targeting improved NIM and credit growth below recent support levels.|Quick check: RELIANCE bullish bias (+1.2% 1d), JSWSTEEL bullish bias (+0.1% 1d).
Mintabout 1 month ago+24

L Catterton hires Chetan Naik to deepen India consumer bets

5 factsFMCGRetail
Maintain a bullish bias on quality consumer stocks, especially those with strong brand equity and distribution networks, as they could attract investment.|Quick check: HINDUNILVR bearish bias (-7.1% 1d), ITC neutral (-0.3% 1d).
Economic Timesabout 1 month ago-53.5

Delhi High Court orders winding up of Paytm Payments Bank after RBI licence cancellation

Neutral5 factsPAYTMFinancial ServicesFintech
Maintain a bearish bias on fintech entities with known regulatory compliance issues; consider short positions or avoiding exposure until clarity emerges on their operational stability.|Quick check: PAYTM bullish bias (+1.4% 1d), HDFCBANK bearish bias (oversold).
Economic Timesabout 1 month ago+11.2

Malabar Gold & Diamonds ropes in M S Dhoni as brand ambassador

Neutral5 factsTITANRetailFinancial Services
Maintain a neutral to slightly positive bias on listed jewelry and gold finance stocks, watching for volume and sales growth as a confirmation.|Quick check: TITAN bullish bias (overbought), HINDUNILVR bearish bias (-7.1% 1d).
Economic Timesabout 1 month ago+68.3

Dr Lal Path Labs shares soar 8% after Q1 earnings beat estimates. What Nomura, Nuvama, other brokerages are saying?

Bullish5 factsLALPATHLABHealthcare
Bullish bias for Dr Lal Path Labs; look for consolidation before further upward movement. This news is stale, so the initial reaction has likely occurred.|Quick check: NIFTY bullish bias (+13.3% 1d).
Economic Timesabout 1 month ago+62.9

Stocks to buy in 2026 for long term: Dr Lal PathLabs, IDFC First Bank among 5 stocks that could give 10-30% return

Bullish5 factsLALPATHLABIDFCFIRSTBBanking
Bullish for Dr Lal PathLabs; consider long positions.|Quick check: LALPATHLAB bullish bias (overbought), IDFCFIRSTB bullish bias (+4.9% 1d).
Economic Timesabout 1 month ago+64

French auto parts maker Forvia to invest €70 m more in India

Neutral5 factsMARUTIMOTHERSONAuto
Bullish for auto OEMs and auto component manufacturers.|Quick check: MARUTI neutral (+2.1% 1d), MOTHERSON bullish bias (overbought).
Economic Timesabout 1 month ago-56.8

Dr Reddy’s shares crash 9% after weak Q1 results. Here’s why these 3 brokerages are bearish

5 factsPharmaceuticals
Maintain a cautious bias on the pharma sector; consider shorting DRL on rallies or avoiding fresh long positions in the near term.|Quick check: SUNPHARMA bullish bias (+0.1% 1d), CIPLA bearish bias (-0.7% 1d).
Economic Timesabout 1 month ago+68.3

Dr Reddy’s aims to resume semaglutide supply by November after API fix

Bullish5 factsDRLPharmaceuticals
Given the positive resolution for DRL, a long bias is warranted, but monitor for any further regulatory hurdles or competitive pressures.|Quick check: DRL bullish bias (overbought), SUNPHARMA bullish bias (+0.1% 1d).
Economic Timesabout 1 month ago-36.7

Tariff hike by US will only increase drug prices: Dr Reddy's CEO

Bullish5 factsDRLPharma
Maintain a bearish bias on Indian pharma stocks with high US generics exposure, anticipating margin pressure.|Quick check: DRL bullish bias (overbought), SUNPHARMA bullish bias (+0.1% 1d).
Mintabout 1 month ago-57.4

Dr Reddy’s reports muted Q1FY27 results, net profit drops 69%

5 factsPharmaceuticals
Negative bias for Dr Reddy's; cautious approach for the broader pharma sector until more clarity emerges.|Quick check: MARUTI neutral (+0.9% 1d), TATAMOTORS bearish bias (-0.7% 1d).
Mintabout 1 month ago+44.9

Q1 results 2026: Eternal to Adani Power among companies to declare Q1 results today; full list here

Bullish4 factsADANIPOWERNESTLEINDADANIGREENBanking
High volatility expected for specific stocks; focus on post-earnings analysis and guidance.|Quick check: ADANIPOWER neutral (+0.1% 1d), NESTLEIND bullish bias (+0.2% 1d).
Economic Timesabout 1 month ago+45

Dr Reddy's Foundation soil testing lab set to hit 1-lakh sample mark ahead of 2026 rabi season

Bullish5 factsDRLAgricultureChemicals
Consider a long-term bullish bias for companies involved in sustainable agriculture, agri-tech, and specialized agri-inputs, with disciplined risk management.|Quick check: DRL bullish bias (overbought), TCS bullish bias (overbought).
Mintabout 2 months ago+20.5

SC asks Baba Kalyani and Sugandha Hiremath to settle disputes via mediation

5 factsAutomobile AncillariesCapital Goods
For stocks like Bharat Forge, maintain a neutral to cautious stance until clarity emerges from the mediation process. Look for confirmation of resolution before taking significant long positions.|Quick check: NIFTY neutral, SENSEX bullish bias (+0.5% 1d).
Economic Timesabout 2 months ago+10.2

Mumbai-Pune rail disruption: Central Railway cancels 30 trains till July 17, check the full list here

5 factsLogisticsTransportation
Maintain a neutral bias on the broad market; this event is too localized to impact overall index trends. Focus on individual stock-specific news and broader economic indicators.|Quick check: NIFTY neutral, SENSEX bullish bias (+0.5% 1d).
Economic Timesabout 2 months ago-32

Dr Reddy's shares crash 9% in 2 days; brokerages slash target prices after semaglutide supply disruption. What lies ahead?

Bullish5 factsDRLPharmaceuticals
Maintain a cautious bias on DRL; look for confirmation of supply resolution before considering long positions. Monitor other pharma stocks for any spillover sentiment.|Quick check: DRL bullish bias (overbought), SUNPHARMA bullish bias (overbought).
Economic Timesabout 2 months ago-30.7

Dr Reddy’s pauses weight loss drug on quality fears

Bullish5 factsDRLTORNTPHARMPharma
Bearish bias for DRL and affected suppliers; look for short positions or avoid until clarity emerges.|Quick check: DRL bullish bias (overbought), TORNTPHARM bullish bias (overbought).
Mintabout 2 months ago-35.8

Dr Reddy's delays semaglutide supplies due to API issue

Bullish5 factsDRLPharma
Negative bias for DRL; consider short-term bearish strategies or avoiding fresh long positions.|Quick check: DRL bullish bias (overbought), SUNPHARMA bullish bias (overbought).
Economic Timesabout 2 months ago-40.8

Dr Reddy's shares slide 7% after delay in semaglutide supplies over quality concerns

Bullish5 factsDRLPharmaceuticals
Maintain a cautious stance on DRL in the short term, looking for clarity on the supply issue resolution. Consider short positions or avoiding fresh long positions until the situation stabilizes.|Quick check: DRL bullish bias (overbought), SUNPHARMA neutral (-0.8% 1d).
Economic Timesabout 2 months ago-47.1

Dr Reddy's flags quality issue in semaglutide batches, delays commercial supplies

Bullish5 factsDRLPharmaceuticals
Given the negative news for DRL, a bearish bias is warranted for the stock in the short term. Traders should look for confirmation of downward momentum.|Quick check: DRL bullish bias (overbought), NIFTY neutral (+33.5% 1d).
Economic Timesabout 2 months ago+48.6

RBI approves Mahesh M Pai as new MD at South Indian Bank

Neutral5 factsSOUTHBANKBanking
For SOUTHBANK, a short-term bearish bias is evident due to the sharp price drop; consider short positions or wait for clear reversal signals before initiating long trades.|Quick check: SOUTHBANK neutral (+1.3% 1d), SENSEX neutral (+0.5% 1d).
Economic Timesabout 2 months ago+14.2

Mumbai rains: Train services between Neral and Karjat suspended for an hour due to overflowing Ulhas river

5 factsLogisticsInfrastructure
Maintain a bullish bias on banking stocks, focusing on those with strong credit growth and improving asset quality, as this news is irrelevant to the sector.|Quick check: HDFCBANK bullish bias (overbought), ICICIBANK neutral (-1.0% 1d).
Economic Timesabout 2 months ago+60.8

India at cusp of 'snacking renaissance'; L Catterton bets on healthy snacking, branded foods

Bullish5 factsNESTLEINDDABURConsumer DiscretionaryFood Processing
Positive bias for FMCG and consumer discretionary stocks, especially those with strong brand equity and innovation in food.|Quick check: NESTLEIND bullish bias (overbought), DABUR bullish bias (overbought).
Economic Times2 months ago+44.2

Generics must not be imperiled over data protection: Satish Reddy, Chairman, Dr Reddy's Laboratories

Bullish5 factsDRLSUNPHARMACIPLAPharma
Maintain a neutral to cautious stance on the pharma sector, awaiting clarity on policy direction and government support for innovation.|Quick check: DRL bullish bias (overbought), SUNPHARMA bullish bias (+0.2% 1d).
Economic Times2 months ago-3.7

Dr Reddys Share Price Live Updates: Dr. Reddy's Laboratories experiences high trading volume

Bearish3 factsDRLBroad Market
Observe DRL for technical breakouts/breakdowns, using volume as a potential confirmation signal.|Quick check: DRL neutral, NIFTY bearish bias (-73.6% 1d).
Economic Times2 months ago+43.3

Dr Reddys Share Price Live Updates: Dr. Reddy's Laboratories achieves 6.16% return in one week

Bullish4 factsDRLAuto
Long bias for DRL; look for entry points on minor pullbacks or breakout confirmations.|Quick check: DRL neutral, MARUTI bullish bias (+4.1% 1d).
Mint2 months ago+36

Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday - 29 June 2026

Bullish4 factsDRLTATACONSUMPharmaceuticalsAutomobiles
For Tata Consumer (FMCG), a buy recommendation suggests potential short-term upside; traders should assess current demand trends and price-volume mix for confirmation.|Quick check: DRL neutral, TATACONSUM bullish bias (+3.2% 1d).
Economic Times2 months ago+51.2

India needs innovation at scale to fulfill ambition of becoming global discovery hub: Dr Reddy's

Bullish5 factsDRLSUNPHARMAPharmaceuticalsHealthcare
Maintain a bullish bias on established Indian pharmaceutical companies with strong R&D pipelines, looking for dips as accumulation opportunities.|Quick check: DRL neutral, SUNPHARMA bullish bias (overbought).
Mint2 months ago+17.4

Auto components maker Interface in talks to sell majority stake at $300 m valuation

5 factsAuto
Neutral to positive bias for the auto components sector; look for M&A targets or companies with strong fundamentals.|Quick check: MARUTI neutral (-0.1% 1d), TATAMOTORS bearish bias (+0.5% 1d).
Economic Times2 months ago-2

Dr Reddys Share Price Live Updates: Dr. Reddys Stock Details

2 factsBroad Market
No specific trade setup. DRL's movement will be dictated by broader pharma sector trends and company-specific news.|Quick check: NIFTY bullish bias (+14.2% 1d), BANKNIFTY bearish bias (-18.6% 1d).
Economic Times2 months ago+66.4

Hotel chains unfazed despite geopolitical shocks, high fuel costs

Bullish5 factsECLERXLEMONTREETAJATSHospitalityTravel & Tourism
Maintain a bullish bias on Indian hotel stocks, focusing on companies with strong domestic presence and healthy balance sheets below recent support levels.|Quick check: ECLERX neutral (-0.4% 1d), LEMONTREE bullish bias (+3.1% 1d).
Economic Times2 months ago+14.4

El Nino fear pushes farmers in Srikakulam and Vizianagaram towards water-saving paddy methods

Neutral5 factsDRLAgricultureChemicals
Maintain a bullish bias on select power sector stocks, focusing on those with strong fundamentals and growth prospects, while monitoring for any policy shifts or climate-related impacts on energy demand.|Quick check: DRL neutral, RELIANCE neutral (+0.3% 1d).
Mint3 months ago+38.3

Karnataka HC says ED acted illegally in arresting Gameskraft founders, orders immediate release

5 factsTechnologyOnline Gaming
Maintain a bullish bias on the broader Indian market; look for opportunities in IT services and potentially unlisted online gaming companies as sentiment improves, with risk discipline around regulatory clarity.|Quick check: NIFTY neutral, BANKNIFTY bearish bias (-29.9% 1d).
Economic Times3 months ago+30.2

Homebuyers 'fraud' case: ED attaches fresh assets worth Rs 503 crore of Raheja Developers

5 factsReal Estate
Investors should favor listed real estate companies with robust corporate governance and a proven track record of project delivery, as these are likely to be perceived as safer bets amidst increased regulatory scrutiny. Maintain a selective approach.|Quick check: MARUTI bullish bias (+3.4% 1d), TATAMOTORS bullish bias (+1.3% 1d).
Economic Times3 months ago+42.9

Chenani-Nashri's two-lane tube tunnel gets green light: Union Minister Jitendra Singh

5 factsInfrastructureConstruction
Maintain a bullish bias on infrastructure stocks, focusing on companies with strong balance sheets and proven execution capabilities in large-scale projects. Implement strict risk management.|Quick check: NIFTY neutral, BANKNIFTY neutral.
Economic Times3 months ago-15.2

Dr Reddys Share Price Live Updates: Dr. Reddy's Laboratories weekly performance shows decline

Neutral3 factsDRLBroad Market
Maintain a cautious or bearish bias on DRL in the short term.|Quick check: DRL neutral, NIFTY neutral.
Economic Times3 months ago+6.2

Dr Reddys Share Price Live Updates: Dr. Reddy's Laboratories shows low beta, indicating stability.

Neutral3 factsDRLBroad MarketPharma
Neutral, but attractive for defensive positioning. Consider for long-term, stable growth.|Quick check: DRL neutral, NIFTY neutral.
Economic Times3 months ago-2.1

Dr Reddys Share Price Live Updates: Dr. Reddy's Laboratories trading volume report

Bearish4 factsDRLBroad Market
Observe price direction with volume; high volume on up move is bullish, on down move is bearish.|Quick check: DRL neutral, NIFTY bearish bias (-27.5% 1d).
Economic Times3 months ago+50.6

India asks state fuel retailers to build LPG storage for 30 days' demand, official says

Neutral5 factsIOCBPCLHPCLOil & GasInfrastructure
Focus on OMCs (IOC, BPCL, HPCL) for potential long-term infrastructure-driven growth; look for dips to accumulate.|Quick check: IOC bullish bias (+0.0% 1d), BPCL neutral (-2.8% 1d).
Economic Times3 months ago-4.3

Dr Reddys Share Price Live Updates: Dr. Reddy's Laboratories shows resilience with 3M returns

Neutral3 factsDRLBroad Market
No trade setup possible from this article.|Quick check: DRL neutral, NIFTY bearish bias (oversold).
Economic Times3 months ago+8.8

Dr Reddys Share Price Live Updates: Dr. Reddys News

Neutral5 factsDRLPharmaceuticals
For DRL, maintain a neutral to slightly bearish bias given recent negative news, but be prepared for short-term bounces..|Quick check: DRL neutral, NIFTY neutral.
Mint3 months ago+4.2

M R Maniveni Foods IPO allotment date likely today; GMP, steps to check share allotment status online for SME IPO

4 factsBroad Market
For those allotted shares, prepare for potential listing day volatility; for others, observe listing performance as a gauge for SME market sentiment.|Quick check: NIFTY neutral (-98.5% 1d), BANKNIFTY neutral.
Economic Times3 months ago+66.6

After 4 rounds of fuel price hike, oil marketing companies ‘losing around Rs 600 cr per day: Ministry of (MoPNG), Sujata Sharma

Bullish5 factsIOCEnergy
Negative bias for OMCs. Look for signs of government intervention or price deregulation as potential catalysts.|Quick check: IOC bullish bias (+3.1% 1d), RELIANCE neutral (+0.6% 1d).
Mint3 months ago+23.1

M R Maniveni IPO Day 1: Issue booked 65% so far, NIIs steal the show. Check GMP, key details to know

5 factsFood ProcessingCapital Markets
For food processing stocks, look for companies with strong brand recall and distribution networks. Bias is neutral to slightly positive for well-managed companies in this sector.|Quick check: TATASTEEL neutral (+0.8% 1d), HINDALCO bullish bias (+1.4% 1d).
Mint3 months ago+36.7

Stocks to watch: LIC, ITC, RVNL, Dr Reddy's among 10 shares in focus today; check list here

Neutral5 factsLICITCRVNLBroad Market
Look for early momentum in these stocks; consider long positions if positive sentiment holds.|Quick check: LIC neutral, ITC neutral (-0.9% 1d).
Economic Times3 months ago+55

Dr Reddy’s launches oral semaglutide in India

Bullish5 factsDRLPharma
Positive bias for DRL. Look for sustained volume growth and market penetration for Obeda.|Quick check: DRL neutral, SUNPHARMA bullish bias (-0.1% 1d).
Economic Times3 months ago+44.6

Dr Reddy's launches oral semaglutide biosimilar Obeda in India

Neutral5 factsDRLLUPINSUNPHARMAPharmaceuticals
Positive bias for DRL; monitor sales trajectory and competitive landscape.|Quick check: DRL neutral, LUPIN neutral (-0.4% 1d).
Economic Times3 months ago+8.8

DG ICAR Jat felicitates progressive millet farmer K Chikkana at ICAR-IIMR

5 factsBroad Market
Long-term positive bias for agri-input and food processing companies with exposure to millets.|Quick check: NIFTY neutral, BANKNIFTY neutral (+0.0% 1d).
Mint4 months ago+19.6

L Catterton said to be in talks to acquire minority stake in Bengaluru-based Nandhana Palace

5 factsHospitalityFood Services
Consider a long bias on select listed QSR and restaurant stocks on dips, anticipating positive sentiment from increased PE activity.|Quick check: NIFTY neutral, BANKNIFTY neutral.
Economic Times4 months ago+59.1

Dr Reddy’s launches generic Semaglutide injection, popular weight-loss drug, in Canada

Bullish5 factsDRLPharma
Positive bias for DRL; look for sustained volume and revenue growth from this new product.|Quick check: DRL neutral, SUNPHARMA bullish bias (+0.9% 1d).
Economic Times4 months ago+9.7

SC appointed panel says all deals involving Supertech Realtors' project need its approval

5 factsReal Estate
Maintain a neutral to cautious stance on real estate developers, focusing on those with strong balance sheets and clear project pipelines.|Quick check: MARUTI neutral (+1.0% 1d), TATAMOTORS bullish bias (+5.2% 1d).
Mint4 months ago-57.8

Dr Reddy's Laboratories shares volatile after an 86% YoY decline in Q4 profit. Should you buy?

Neutral5 factsDRLPharmaceuticals
Given the negative news for DRL, a bearish bias is warranted for the stock; consider short-term downside plays.|Quick check: DRL neutral, NIFTY neutral.
Economic Times4 months ago-49.1

Dr Reddy's shares in focus after Q4 net profit tumbles 86% YoY; Morgan Stanley, Goldman Sachs weigh in

Neutral5 factsDRLPharmaceuticals
Maintain a cautious stance on DRL; consider short positions or avoiding fresh long entries until clarity emerges on profitability drivers.|Quick check: DRL neutral, SUNPHARMA bullish bias (overbought).
Economic Times4 months ago-60.7

Dr Reddy's Laboratories Q4 Results: Cons PAT falls 86% YoY to Rs 221 crore, revenue dips 12%; Rs 8 per share dividend announced

Neutral5 factsDRLPharmaceuticals
Given Dr. Reddy's significant earnings miss, a bearish bias is warranted for DRL. Traders should look for confirmation of downside momentum and manage risk.|Quick check: DRL neutral, MARUTI bearish bias (-2.3% 1d).
Mint4 months ago-60.1

Dr Reddy's Q4 results 2026: Profit plunges 86% YoY to ₹220 crore; board recommends a final dividend of ₹8

Neutral4 factsDRLPharmaceuticals
Maintain a cautious to bearish bias on DRL; consider downside risk above recent resistance levels.|Quick check: DRL neutral, TATASTEEL neutral (-0.2% 1d).
Mint4 months ago+38.2

Stocks to buy: Sagar Doshi suggests Dr Reddys, Grasim, and HUL shares to buy

Bullish5 factsGRASIMPharmaceuticalsDiversified
Given the rising crude prices, consider a bearish bias for oil marketing companies (OMCs) and industries with high energy consumption, while looking for defensive plays or companies with pricing power.|Quick check: GRASIM bullish bias (overbought), NIFTY neutral.
Mint4 months ago+42.6

Q4 results 2026: Tata Power to Dr Reddy's among companies to declare Q4 results today; full list here

Neutral5 factsTATAPOWERDRLPowerPharmaceuticals
For auto stocks, maintain a bearish bias given recent declines; look for confirmation in Q4 results regarding volume growth and discounting pressures.|Quick check: TATAPOWER neutral (oversold), DRL neutral.
Economic Times4 months ago+8

China’s 90% Supremacy Model: The chokehold and the way out | ET Titan Talks with Dr Ram Charan

5 factsBroad Market
Neutral for short-term; long-term positive for sectors benefiting from 'China+1' strategies or import substitution.|Quick check: NIFTY neutral, BANKNIFTY neutral.
Economic Times4 months ago-48.2

Fin services secy warns banks of mythos risks

Neutral5 factsHDFCBANKICICIBANKBanking
Neutral to slightly bearish bias for banking stocks due to potential increased compliance costs.|Quick check: HDFCBANK neutral (-0.1% 1d), ICICIBANK bearish bias (oversold).
Economic Times4 months ago+37.3

MSME min scheme created 36 L jobs during FY22-26

Bullish5 factsBroad MarketAuto
Positive bias for rural consumption and MSME-linked financial stocks; look for entry points on dips.|Quick check: MARUTI bullish bias (+0.3% 1d), TATAMOTORS bullish bias (+0.3% 1d).
Economic Times4 months ago+45

Dr Reddy's and Nestle Health Science strengthen presence in diabetes, obesity nutrition space

Neutral5 factsDRLPharmaceuticalsHealthcare
Positive bias for DRL; look for sustained volume and price action above recent resistance levels.|Quick check: DRL neutral.
Economic Times4 months ago+35.2

Beware! Finance Secretary Nagaraju warns banks about risk from Mythos

5 factsBankingIT
Negative bias for banking stocks due to potential increased compliance costs and operational risks. Positive bias for cybersecurity and AI risk management solution providers.|Quick check: HDFCBANK neutral (-0.1% 1d), ICICIBANK bearish bias (oversold).
Economic Times4 months ago+24.2

NCLT upholds Aanand Rai's plea in row with Eros International

Bearish5 factsEROSMEDIABanking
Maintain a bearish bias on Eros International Media. Avoid fresh long positions and consider downside risk if technicals align.|Quick check: EROSMEDIA neutral, HDFCBANK bearish bias (oversold).
Mint4 months ago+25.8

TVK poised for Tamil Nadu win: What Thalapathy Vijay’s victory could mean for companies operating in the state

4 factsEnergy
Neutral to cautious for companies heavily invested in Tamil Nadu until policy clarity emerges.|Quick check: RELIANCE bullish bias (overbought), ONGC neutral (-2.0% 1d).
Mint4 months ago-51.4

Tamil Nadu election results impact: Why have Sun TV Network shares crashed over 9% today?

Neutral5 factsSUNTVMediaBroad Market
Short-term bearish bias for SUNTV; monitor for further political news or company statements.|Quick check: SUNTV neutral (+3.9% 1d), NIFTY neutral.
Economic Times4 months ago+6.8

ET Titan Talks | Dr Ram Charan | How to Build a CEO War Room for 2026

5 factsManagement ConsultingCorporate Governance
Maintain a neutral bias on the broad market based on this strategic discussion; focus on company-specific fundamentals and management quality for long-term positions.|Quick check: NIFTY neutral, SENSEX neutral.